Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?

Vaccine

Volumn 31, Issue 41, 2013, Pages 4541-4547

  Van der Maas, Nicoline A T ^a   Mooi, Frits R ^a   de Greeff, Sabine C ^a   Berbers, Guy A M ^a   Spaendonck, Marina A E Conyn van ^a   de Melker, Hester E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Adults; Incidence; Infants; Pertussis; Vaccination; Vaccine effectiveness; Whooping cough

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; BACTERIAL TRANSMISSION; CHILD; CHILD HOSPITALIZATION; CLINICAL EFFECTIVENESS; EPIDEMIC; HEALTH CARE PLANNING; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NETHERLANDS; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADULTS; INCIDENCE; INFANTS; PERTUSSIS; VACCINATION; VACCINE EFFECTIVENESS; WHOOPING COUGH;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; FEMALE; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NETHERLANDS; PERTUSSIS VACCINE; TREATMENT OUTCOME; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84883580177     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.060     Document Type: Article

References (34)

1. Vegelin A.L., van Vught A.J., Wolfs T.F., Kimpen J.L., Geelen S.P. [Pertussis in young infants]. Ned Tijdschr Geneeskd 1998, 142(49):2657-2660. Epub 1999/03/05. Kinkhoest bij de jonge zuigeling.
2. De Serres G., Shadmani R., Duval B., Boulianne N., Dery P., Douville Fradet M., et al. Morbidity of pertussis in adolescents and adults. The Journal of Infectious Diseases 2000, 182(1):174-179. Epub 2000/07/.
3. de Greeff S.C., de Melker H.E., van Gageldonk P.G., Schellekens J.F., van der Klis F.R., Mollema L., et al. Seroprevalence of Pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS ONE 2010, 5(12):e14183. Epub 2010/12/15.
4. Zhang L., Prietsch S.O., Axelsson I., Halperin S.A. Acellular vaccines for preventing whooping cough in children. Cochrane Database of Systematic Reviews 2011, (1):CD001478. Epub 2011/01/21.
5. Edwards K.M., Meade B.D., Decker M.D., Reed G.F., Rennels M.B., Steinhoff M.C., et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995, 96(3 Pt 2):548-557. Epub 1995/09/01.
6. Cherry J.D. Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease. The New England Journal of Medicine 2012, 367(9):785-787. Epub 2012/08/17.
7. de Melker H.E., Schellekens J.F., Neppelenbroek S.E., Mooi F.R., Rumke H.C., Conyn-van Spaendonck M.A. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerging Infectious Diseases 2000, 6(4):348-357. Epub 2000/07/25.
8. Grant C.C., Reid S. Pertussis continues to put New Zealand's immunisation strategy to the test. The New Zealand Medical Journal 2010, 123(1313):46-61. Epub 2010/06/29.
9. Moerman L., Leventhal A., Slater P.E., Anis E., Yishai R., Marva E. The re-emergence of pertussis in Israel. The Israel Medical Association Journal 2006, 8(5):308-311. Epub 2006/06/30.
10. van 't Klooster T.M., De Melker H. The National Immunization Programme in the Netherlands: Developments in 2011 2011, National Institute for Public Health and the Environment, Bilthoven, Contract No.: 210021015/2011.
11. Environment NIfPHat, 2012. http://www.rivm.nl/Onderwerpen/Ziekten_Aandoeningen/K/Kinkhoest.
12. Guiso N., Berbers G., Fry N.K., He Q., Riffelmann M., Wirsing von Konig C.H. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. European Journal of Clinical Microbiology & Infectious Diseases 2011, 30(3):307-312. Epub 2010/11/12.
13. Farrington C.P. Estimation of vaccine effectiveness using the screening method. International Journal of Epidemiology 1993, 22(4):742-746. Epub 1993/08/01.
14. Van Lier A., Oomen P.J., Giesbers H., Drijfhout I.H., De Hoogh P.A.A.M., de Melker H.E. Immunization Coverage National Immunization Programme in the Netherlands 2012, National Institute for Public Health and the Environment, Bilthoven, 201001001/2012.
15. de Greeff S.C., Mooi F.R., Westerhof A., Verbakel J.M., Peeters M.F., Heuvelman C.J., et al. Pertussis disease burden in the household: how to protect young infants. Clinical Infectious Diseases 2010, 50(10):1339-1345. Epub 2010/04/08.
16. Klein N.P., Bartlett J., Rowhani-Rahbar A., Fireman B., Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. The New England Journal of Medicine 2012, 367(11):1012-1019. Epub 2012/09/14.
17. Witt M.A., Katz P.H., Witt D.J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clinical Infectious Diseases 2012, 54(12):1730-1735. Epub 2012/03/17.
18. Anonymous Whooping cough vaccination; coverage may be widened. British Medical Journal (Clinical Research Ed.) 2012, 345(7868):E5201.
19. Billingsley M. Pregnant women in UK are offered whooping cough vaccine to protect newborns. BMJ 2012, 345:e6594. Epub 2012/10/10.
20. Centers for Disease Control and Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Morbidity and Mortality Weekly Report (MMWR) 2011, 60(1):13-15. Epub 2011/01/14.
21. Wei S.C., Tatti K., Cushing K., Rosen J., Brown K., Cassiday P., et al. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis. Clinical Infectious Diseases 2010, 51(3):315-321. Epub 2010/06/29.
22. Ulloa-Gutierrez R., Gentile A., Avila-Aguero M.L. Pertussis cocoon strategy: would it be useful for Latin America and other developing countries?. Expert Review of Vaccines 2012, 11(12):1393-1396. Epub 2012/12/21.
23. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. The Pediatric Infectious Disease Journal 2005, 24(5 Suppl):S58-S61. Epub 2005/05/07.
24. Hendrikx L.H., Berbers G.A., Veenhoven R.H., Sanders E.A., Buisman A.M. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine 2009, 27(47):6530-6536. Epub 2009/09/05.
25. Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infection, Genetics and Evolution 2010, 10(1):36-49. Epub 2009/11/03.
26. van Gent M., Bart M.J., van der Heide H.G., Heuvelman K.J., Kallonen T., He Q., et al. SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS ONE 2011, 6(5):e20340. Epub 2011/06/08.
27. Mooi F.R., van Loo I.H., van Gent M., He Q., Bart M.J., Heuvelman K.J., et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerging Infectious Diseases 2009, 15(8):1206-1213. Epub 2009/09/16.
28. Carbonetti N.H., Artamonova G.V., Van Rooijen N., Ayala V.I. Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infection and Immunity 2007, 75(4):1713-1720. Epub 2007/01/24.
29. Schmidtke A.J., Boney K.O., Martin S.W., Skoff T.H., Tondella M.L., Tatti K.M., et al. Diversity among Bordetella pertussis isolates United States, 1935-2009. Emerging Infectious Diseases 2012, 18(8):1248-1255. Epub 2012/07/31.
30. Kallonen T., Mertsola J., Mooi F.R., He Q. Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR. Clinical Microbiology and Infection 2012, 18(10):E377-E379. Epub 2012/08/23.
31. Barkoff A.M., Mertsola J., Guillot S., Guiso N., Berbers G., He Q. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clinical and Vaccine Immunology 2012, 19(10):1703-1704. Epub 2012/08/24.
32. Bouchez V., Brun D., Cantinelli T., Dore G., Njamkepo E., Guiso N. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. Vaccine 2009, 27(43):6034-6041. Epub 2009/08/12.
33. Queenan A.M., Cassiday P.K., Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. The New England Journal of Medicine 2013, 368(6):583-584. Epub 2013/02/08.
34. Berbers G.A., de Greeff S.C., Mooi F.R. Improving pertussis vaccination. Hum Vaccine 2009, 5(7):497-503. Epub 2009/02/27.